Home > Insider Trading > Filing (0001209191-18-025379)

Filing Details

Accession Number:: 0001209191-18-025379
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-04-18 16:38:17
Reporting Period:: 2018-04-16

Accepted Time:: 2018-04-18 16:38:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
831547	Spectrum Pharmaceuticals Inc	SPPI	Pharmaceutical Preparations (2834)	930979187

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1193918	Md C Rajesh Shrotriya	11500 S. Eastern Ave. Suite 240 Henderson NV 89052		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Disposition	2018-04-16	30,000	$18.72	1,209,977	No	4	S	Indirect	By CS Family Trust
Common Stock, $0.001 Par Value	Disposition	2018-04-17	30,000	$18.56	1,179,977	No	4	S	Indirect	By CS Family Trust
Common Stock, $0.001 Par Value	Disposition	2018-04-18	30,000	$19.71	1,149,977	No	4	S	Indirect	By CS Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By CS Family Trust
No	4	S	Indirect	By CS Family Trust
No	4	S	Indirect	By CS Family Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	1,787,542	Indirect	By Shrotriya Gift Trust
Common Stock, $0.001 Par Value	1,243,284	Indirect	By RS Irrevocable Trust
Common Stock, $0.001 Par Value	28,907	Indirect	By 401(k) Plan
Common Stock, $0.001 Par Value	9,523	Indirect	By Spouse
Common Stock, $0.001 Par Value	67,144	Indirect	By Shrotriya Family Foundation
Common Stock, $0.001 Par Value	200,652	Direct

Footnotes

All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 19, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.41 to $19.20, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.49 to $18.62, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.51 to $20.08, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.